Spironolactone Tablet, Film Coated
Product Images NDC 72162-2150

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 72162-2150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spironolactone Structural Formula (Image 01)

Chemical structure of spironolactone shown as a detailed molecular diagram depicting its steroidal framework with attached functional groups including a lactone ring and a thioacetate moiety.*

FDA Label Image

Figure 1. Survival By Treatment Group In The Randomized Spironolactone Evaluation Study (Image 02)

A Kaplan-Meier survival curve comparing the probability of an event over time in months for two groups: Spironolactone (822 subjects) and Placebo (841 subjects). The y-axis shows probability from 0 to 1 and the x-axis shows time in months up to 48. The Spironolactone group curve is above the Placebo group, and a log-rank p-value less than 0.001 is indicated, suggesting a statistically significant difference between the groups.*

FDA Label Image

Figure 2. Hazard Ratios Of All-cause Mortality By Subgroup In The Randomized Spironolactone Evaluation Study (Image 03)

A forest plot chart showing hazard ratios (HR) and 95% confidence intervals (CI) for various patient subgroups, including age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium levels, and medication use (digoxin, ACEI, beta blocker). The x-axis ranges from 0.2 to 1.4, indicating comparison outcomes for spironolactone versus placebo effectiveness.*

FDA Label Image

Label (Lbl721622150)

Label for Spironolactone Tablets USP 25 mg, film-coated oral tablets, in a 500 tablet package. The label includes the NDC 72162-2150, and indicates the product is relabeled by Bryant Ranch Prepack and manufactured by Alphapharm Pty Ltd. Storage instructions specify controlled room temperature and protection from light.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.